Subsequently, to evaluate how changes in CSF GDNF levels could reflect GDNF expression in the striatum where GDNF is highly expressed, we utilised raw data from a previously published transcriptomics study analysing striatal gene expression in post-mortem samples from healthy controls and patients with schizophrenia, bipolar disorder, or major depressive disorder [110]. This evidence concerns the gene GDNF and bipolar disorder.